LDHC and breast carcinoma: In a study by Naik et al., LDHC silencing led to the abrupt progression of the cell cycle with substantial expression alteration in cell cycle checkpoint components, disassembly of nuclear and microtubule components, and DNA damage regulators in breast cancer (80).